PROTECTIVE EFFECT OF SEROTONIN (5-HT(2)) RECEPTOR ANTAGONISTS IN ISCHEMIC RAT HEARTS

被引:21
作者
GROVER, GJ
SARGENT, CA
DZWONCZYK, S
NORMANDIN, DE
ANTONACCIO, MJ
机构
[1] Department of Pharmacology, The Bristol-Myers Squibb Pharmaceutical Research Institute, Princeton, NJ
关键词
MYOCARDIAL ISCHEMIA; SEROTONIN; CINANSERIN; KETANSERIN; LY-53857; CONTRACTILE FUNCTION; REPERFUSION;
D O I
10.1097/00005344-199310000-00022
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Serotonin (5-HT) may play a role in exacerbating thrombosis and coronary spasm during myocardial ischemia, but its role in mediating myocardial damage directly is not clear. We determined the effect of the 5-HT2 receptor antagonists cinanserin (0.1-10 muM), ketanserin (0.3-10 muM), and LY 53857 (1-10 muM) on time to contracture, recovery of contractile function, and lactate dehydrogenase (LDH) release after 25-min global ischemia and 30-min reperfusion in isolated rat heart. All 5-HT2 antagonists significantly increased time to contracture in a concentration-dependent manner (EC25 = 1.6, 5.5, and 6.1 muM for cinansefin, ketanserin, and LY 53857, respectively). These compounds also significantly reduced LDH release and improved recovery of contractile function during reperfusion. 5-HT greater-than-or-equal-to 30 muM significantly reduced time to contracture, indicating a proischemic effect. The proischemic effect of 5-HT was abolished by ketanserin and cinansefin. Inhibition of 5-HT synthesis by parachlorophenylalanine resulted in significant cardio-protection, further indicating the involvement of 5-HT in the pathogenesis of ischemia in this model. Although cinansefin and ketanserin had alpha1-adrenoceptor blocking effects, LY 53857 was devoid of this activity at concentrations exhibiting cardioprotection. Therefore, 5-HT may exacerbate ischemic injury in rat heart, and this exacerbation appears to be mediated specifically by 5-HT, receptors.
引用
收藏
页码:664 / 672
页数:9
相关论文
共 29 条
[11]   5-HT - THE ENIGMA VARIATIONS [J].
FOZARD, JR .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1987, 8 (12) :501-506
[12]   LOCAL PLATELET ACTIVATION CAUSES VASOCONSTRICTION OF LARGE EPICARDIAL CANINE CORONARY-ARTERIES INVIVO - THROMBOXANE-A2 AND SEROTONIN ARE POSSIBLE MEDIATORS [J].
GOLINO, P ;
ASHTON, JH ;
BUJA, LM ;
ROSOLOWSKY, M ;
TAYLOR, AL ;
MCNATT, J ;
CAMPBELL, WB ;
WILLERSON, JT .
CIRCULATION, 1989, 79 (01) :154-166
[13]   MEDIATION OF REOCCLUSION BY THROMBOXANE-A2 AND SEROTONIN AFTER THROMBOLYSIS WITH TISSUE-TYPE PLASMINOGEN-ACTIVATOR IN A CANINE PREPARATION OF CORONARY-THROMBOSIS [J].
GOLINO, P ;
ASHTON, JH ;
GLASGREENWALT, P ;
MCNATT, J ;
BUJA, LM ;
WILLERSON, JT .
CIRCULATION, 1988, 77 (03) :678-684
[14]   DIRECT MYOCARDIAL EFFECTS OF THE THROMBOXANE-A2/ PROSTAGLANDIN-H2 AGONISTS U-46619 AND SQ-26,655 UNDER ISCHEMIC AND NONISCHEMIC CONDITIONS [J].
GROVER, GJ ;
HEDBERG, A ;
OGLETREE, ML .
PHARMACOLOGY, 1990, 41 (01) :1-15
[15]   NICORANDIL IMPROVES POSTISCHEMIC CONTRACTILE FUNCTION INDEPENDENTLY OF DIRECT MYOCARDIAL EFFECTS [J].
GROVER, GJ ;
SLEPH, PG ;
PARHAM, CS .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1990, 15 (05) :698-705
[16]  
GROVER GJ, 1991, J PHARMACOL EXP THER, V257, P156
[17]   5-HYDROXYTRYPTAMINE INDUCES PHOSPHOLIPASE C-MEDIATED HYDROLYSIS OF PHOSPHOINOSITIDES THROUGH 5-HYDROXYTRYPTAMINE-2 RECEPTORS IN CULTURED FETAL MOUSE VENTRICULAR MYOCYTES [J].
HAMAMORI, Y ;
YOKOYAMA, M ;
YAMADA, M ;
AKITA, H ;
GOSHIMA, K ;
FUKUZAKI, H .
CIRCULATION RESEARCH, 1990, 66 (06) :1474-1483
[18]  
HAMM CW, 1983, CIRC RES, V52, P129
[19]  
KOE BK, 1966, J PHARMACOL EXP THER, V154, P499
[20]   INOSITOL PHOSPHOLIPIDS AND CELL-SURFACE RECEPTOR FUNCTION [J].
MICHELL, RH .
BIOCHIMICA ET BIOPHYSICA ACTA, 1975, 415 (01) :81-147